We are live on
!
Find out more
BIM
BlackRock Investment Management Portfolio holdings
AUM
$86.4B
1-Year Est. Return
28.54%
This Fund
S&P 500
This Quarter
Est. Return
-6.33%
1 Year Est. Return
+28.54%
3 Year Est. Return
+50.87%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.1B
AUM Growth
-$6.38B
(-7.9%)
Cap. Flow
-$3.93M
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
13.95%
Holding
4,270
New
142
Increased
1,362
Reduced
1,963
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$168M |
| 2 |
Sherwin-Williams
SHW
|
+$103M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$101M |
| 4 |
Kraft Heinz
KHC
|
+$93.4M |
| 5 |
Costco
COST
|
+$91.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$137M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 3 |
AbbVie
ABBV
|
+$130M |
| 4 |
JPMorgan Chase
JPM
|
+$111M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.57% |
| 2 | Healthcare | 15.53% |
| 3 | Technology | 12.72% |
| 4 | Industrials | 9.73% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REV
2426
DELISTED
Revlon, Inc.
REV
| $1.25M | ﹤0.01% |
42,298
+376
| +0.9% | +$12.8K |
|
|
OSIR
2427
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $1.25M | ﹤0.01% |
67,429
-2,018
| -3% | -$38.9K |
|
|
ARII
2428
DELISTED
American Railcar Industries, Inc.
ARII
| $1.24M | ﹤0.01% |
34,310
+336
| +1% | +$13.8K |
|
|
STFC
2429
DELISTED
State Auto Financial Corp
STFC
| $1.24M | ﹤0.01% |
54,348
-1,281
| -2% | -$31.3K |
|
|
EPZM
2430
DELISTED
Epizyme, Inc
EPZM
| $1.24M | ﹤0.01% |
96,314
-1,455
| -1% | -$29.4K |
|
|
SCNB
2431
DELISTED
Suffolk Bancorp
SCNB
| $1.24M | ﹤0.01% |
45,352
-354
| -0.8% | -$9.72K |
|
|
PKD
2432
DELISTED
Parker Drilling Company
PKD
| $1.24M | ﹤0.01% |
31,383
-329
| -1% | -$13.9K |
|
|
NAVB
2433
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $1.24M | ﹤0.01% |
27,124
-965
| -3% | -$36.4K |
|
2434
Onto Innovation
ONTO
$20.3B
| $1.24M | ﹤0.01% |
101,725
-977
| -1% | -$13.8K |
|
|
SRDX
2435
DELISTED
Surmodics
SRDX
| $1.23M | ﹤0.01% |
56,449
-615
| -1% | -$14.4K |
|
|
SN
2436
DELISTED
Sanchez Energy Corporation
SN
| $1.23M | ﹤0.01% |
200,484
-1,704
| -0.8% | -$11.5K |
|
|
CACQ
2437
DELISTED
Caesars Acquisition Company
CACQ
| $1.23M | ﹤0.01% |
173,571
-2,008
| -1% | -$14.3K |
|
2438
ANI Pharmaceuticals
ANIP
$1.76B
| $1.23M | ﹤0.01% |
31,160
-517
| -2% | -$29.4K |
|
2439
Titan International
TWI
$445M
| $1.23M | ﹤0.01% |
186,145
-2,886
| -2% | -$25.1K |
|
|
SCTY
2440
DELISTED
SolarCity Corporation
SCTY
| $1.23M | ﹤0.01% |
28,771
-4,069
| -12% | -$204K |
|
2441
Pacific Biosciences
PACB
$357M
| $1.23M | ﹤0.01% |
335,432
-65,099
| -16% | -$318K |
|
|
OKSB
2442
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $1.23M | ﹤0.01% |
74,757
-934
| -1% | -$16.1K |
|
2443
OneMain Financial
OMF
$7.56B
| $1.23M | ﹤0.01% |
28,036
+131
| +0.5% | +$6.14K |
|
|
SFE
2444
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.22M | ﹤0.01% |
78,793
+621
| +0.8% | +$11.1K |
|
|
CZR
2445
DELISTED
Caesars Entertainment Corporation
CZR
| $1.22M | ﹤0.01% |
207,607
-3,191
| -2% | -$23.5K |
|
|
CBL
2446
DELISTED
CBL& Associates Properties, Inc.
CBL
| $1.22M | ﹤0.01% |
88,529
-74,824
| -46% | -$1.16M |
|
2447
Xencor
XNCR
$1.74B
| $1.22M | ﹤0.01% |
99,435
-1,206
| -1% | -$23.6K |
|
2448
Viavi Solutions
VIAV
$10.7B
| $1.22M | ﹤0.01% |
226,204
-1,319,127
| -85% | -$7.74M |
|
|
AEGR
2449
DELISTED
Aegerion Pharmaceuticals
AEGR
| $1.22M | ﹤0.01% |
89,331
-647
| -0.7% | -$11.5K |
|
|
KERX
2450
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.21M | ﹤0.01% |
343,897
-5,668
| -2% | -$38K |
|
Similar funds
BA
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Investment Management's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Investment Management held 4,270 positions worth $74.1B, down 7.9% from $80.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Investment Management's Q3 2015 filing shows 142 new, 1,362 increased, 1,963 reduced and 118 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 2,916,709 shares worth $91.9M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $137M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Technology.
- BlackRock Investment Management's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 2,916,709 shares worth $91.9M.
- BlackRock Investment Management added most to Biogen in Q3 2015, an estimated $168M increase.
- BlackRock Investment Management's biggest Q3 2015 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $137M.
- BlackRock Investment Management fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $105M.
- BlackRock Investment Management's ten largest holdings make up 14% of its $74.1B portfolio in Q3 2015.
- BlackRock Investment Management opened 142 new positions and closed 118 in Q3 2015.
- BlackRock Investment Management's portfolio value fell 7.9% quarter-over-quarter to $74.1B.
Based on BlackRock Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.